IR@PKUHSC  > 北京大学第三临床医学院  > 眼科
学科主题临床医学
Bevacizumab Treatment for Acute Branch Retinal Vein Occlusion Accompanied by Subretinal Hemorrhage
Zhao, Lin; Li, Bingzhen; Feng, Kang; Han, Liang; Ma, Zhizhong; Liu, Yuling
关键词Bevacizumab branch retinal vein occlusion macular edema optical coherence tomography subretinal hemorrhage
刊名CURRENT EYE RESEARCH
2015-07-01
DOI10.3109/02713683.2014.952827
40期:7页:752-756
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Ophthalmology
研究领域[WOS]Ophthalmology
关键词[WOS]OPTICAL COHERENCE TOMOGRAPHY ; SEROUS MACULAR DETACHMENT ; INTRAVITREAL BEVACIZUMAB ; EDEMA ; THERAPY
英文摘要

Purpose: The purpose of this study was to compare the efficacy of intravitreal bevacizumab (IVB) in the treatment of acute (53 months [mo]. duration) macular edema (ME), with or without subretinal hemorrhage (SRH), resulting from branch retinal vein occlusion (BRVO).

Materials and methods: We conducted a retrospective review of 33 consecutive patients (n = 33 eyes) with ME caused by acute BRVO. All patients received an injection of IVB at baseline examination. All patients were followed monthly, with administration of additional IVB injections if there was persistent or recurrent ME. Specific patterns of ME were investigated using spectral-domain optical coherence tomography (SD-OCT).

Results: SD-OCT revealed serous retinal detachments in the fovea of 15 eyes, 10 of which had accompanying foveal SRH. Based on initial detection of foveal SRH, patients were divided into SRH-negative (n = 23 eyes) or SRH-positive (n = 10 eyes) groups. Initial best-corrected visual acuity (BCVA) did not differ between the two groups. In the SRH-negative group, both BCVA and central macular thickness (CMT) improved significantly after IVB injections (mean, 2.3 injections) at the 6-mo. follow-up examination. In the SRH-positive group, there was no significant improvement in BCVA after IVB injections (mean, 2.0 injections), although there was a significant decrease in CMT. The final BCVA of the SRH-positive group was significantly poorer than that of the SRH-negative group (p = 0.001).

Conclusion: The presence of foveal SRH may be a negative predictor of IVB treatment outcomes for BRVO patients with ME.

语种英语
WOS记录号WOS:000359858000012
引用统计
被引频次:3[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/61434
专题北京大学第三临床医学院_眼科
北京大学基础医学院
作者单位Peking Univ, Hosp 3, Ctr Eye, Dept Ophthalmol,Key Lab Vis Loss & Restorat,Minis, Beijing 100191, Peoples R China
推荐引用方式
GB/T 7714
Zhao, Lin,Li, Bingzhen,Feng, Kang,et al. Bevacizumab Treatment for Acute Branch Retinal Vein Occlusion Accompanied by Subretinal Hemorrhage[J]. CURRENT EYE RESEARCH,2015,40(7):752-756.
APA Zhao, Lin,Li, Bingzhen,Feng, Kang,Han, Liang,Ma, Zhizhong,&Liu, Yuling.(2015).Bevacizumab Treatment for Acute Branch Retinal Vein Occlusion Accompanied by Subretinal Hemorrhage.CURRENT EYE RESEARCH,40(7),752-756.
MLA Zhao, Lin,et al."Bevacizumab Treatment for Acute Branch Retinal Vein Occlusion Accompanied by Subretinal Hemorrhage".CURRENT EYE RESEARCH 40.7(2015):752-756.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhao, Lin]的文章
[Li, Bingzhen]的文章
[Feng, Kang]的文章
百度学术
百度学术中相似的文章
[Zhao, Lin]的文章
[Li, Bingzhen]的文章
[Feng, Kang]的文章
必应学术
必应学术中相似的文章
[Zhao, Lin]的文章
[Li, Bingzhen]的文章
[Feng, Kang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。